First-principles physics combined with generative AI unlocks challenging targets

We are advancing a differentiated pipeline with first and best-in-class potential across oncology and autoimmune indications

Discovery header mobileWe are advancing 8 internal programs across diverse target classes for Oncology, Autoimmune and Rare disease